Overall impact
B (77)

Commentary

Baxter is a strong overall performer. With a 'B' rating of 77.0 for overall impact (91st percentile compared to all companies), Baxter ranks 11th out of 112 industry peers, behind Ansell, Endologix, RA Medical Systems and 7 others, and ahead of InfuSystem, LifeScan, Orthopediatrics and 98 others. On top material causes for Baxter's industry (Health Care Equipment & Supplies), Baxter performs well in Improved Mental Health (92.5 score), Equal Pay and Opportunity (95.2), Racial Justice and Civil Rights (94.8) and 7 other causes where it received an 'A' score and performs poorly in Decent, Safe Work Opportunities (32.1 score), Accountable Institutions (39.6), Sustainable Use of Natural Resources (21.9) and 4 other causes where it received a 'D' or 'F' score.
Impact
Cause BAX
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
1931
Employees
38,000
Sector
Health Care
Industry
Health Care Equipment & Supplies
Sub-industry
Health Care Supplies
SASB industry
Medical Equipment & Supplies
Headquarters
Il, United States
Share classes
BAX
Mission
To provide excellent care for every patient, every time
Description
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; administrative sets; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices. Additionally, it provides advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also offers specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. Baxter sells its products through a direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It has an agreement with Celerity Pharmaceuticals, LLC to develop acute care generic injectable premix and oncolytic products. The company operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Material causes
Ethos considers the following causes material for Baxter, based on its industry sub-industry Health Care Supplies. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.